The Effect of Betamethasone Dosing Interval on Perinatal Outcomes: 12 Hours or 24 Hours Apart
American Journal of Perinatology · 01.09.2023 · 40 (12) · 1351-1358
DOI: 10.1055/s-0041-1735962 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Perinatology, erschienen am 01.09.2023. Verfasst von Ayca Nazli Bulut und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Kayseri City Training and Research Hospital, Kayseri, Turkey. Hauptthemen laut MEDLINE: Respiratory Distress Syndrome, Newborn, Pulmonary Surfactants. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 14 Literaturangaben.
Abstract (Originalsprache)
Objective
Antenatal steroids are commonly used to stimulate fetal lung maturation, particularly in pregnancies at risk of early preterm labor. This study aimed to compare the effects of administering betamethasone at a 12- versus 24-hour interval on perinatal outcomes. Study Design This retrospective study included 423 early preterm births from 26+0/7 to 33+6/7 weeks of gestation. Patients received betamethasone at either a 12- or 24-hour dosing interval.
Results
When all patients in each group were evaluated together, there was no statistically significant difference between both groups for complications of prematurity, including respiratory distress syndrome (RDS). When the two groups were divided by gestational age (GA), the 32+0/7 to 33+6/7-week group that received betamethasone at a 24-hour interval had statistically lower 1- and 5-minute APGAR scores (p = 0.06 and p = 0.02, respectively). They also had a greater need for neonatal intensive care unit (NICU), NICU length of stay, RDS, and need for surfactant (p = 0.20, p = 0.09, p = 0.27, and p = 0.23, respectively) than did the infants at 32+0/7 to 33+6/7 weeks, who received betamethasone at a 12-hour interval. In the group with GA between 28+0/7 and 29+6/7 weeks, the 1-minute APGAR score was lower (p = 0.22), and the durations of hospital stay, and mechanical ventilation were longer (p = 0.048, p = 0.21, respectively) in the 24-hour interval group. No statistically significant difference was observed for all parameters in other GA groups.
Conclusion
A 12-hour dosing interval for betamethasone appears to be more appropriate, as it results in a reduction in some neonatal complications and provides a short dose interval. Key Points
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Kayseri City Training and Research Hospital, Kayseri, Turkey.
- Department of Obstetrics and Gynecology, Istanbul Medipol University, Istanbul, Turkey.
ORCID-Profile: Ayca Nazli Bulut, Emine Aydin
Zitieren
APA
Bulut, A. N., Ceyhan, V., Cundubey, C. R., & Aydin, E. (2023). The Effect of Betamethasone Dosing Interval on Perinatal Outcomes: 12 Hours or 24 Hours Apart. American Journal of Perinatology, 40(12), 1351-1358. https://doi.org/10.1055/s-0041-1735962
Vancouver
Bulut AN, Ceyhan V, Cundubey CR, Aydin E. The Effect of Betamethasone Dosing Interval on Perinatal Outcomes: 12 Hours or 24 Hours Apart. American Journal of Perinatology. 2023;40(12):1351-1358. doi:10.1055/s-0041-1735962
BibTeX
@article{Bulut2023,
author = {Bulut, Ayca Nazli and Ceyhan, Venhar and Cundubey, Cevat Rifat and Aydin, Emine},
title = {The Effect of Betamethasone Dosing Interval on Perinatal Outcomes: 12 Hours or 24 Hours Apart},
journal = {American Journal of Perinatology},
year = {2023},
volume = {40},
number = {12},
pages = {1351--1358},
doi = {10.1055/s-0041-1735962}
}
EUVIMED